Editorials

• Insights into the 2025 ESC clinical consensus on mental health and cardiovascular disease

  SEC Working Group for the 2025 ESC clinical consensus on mental health and cardiovascular disease and SEC Guidelines Committee

  Rev Esp Cardiol. 2026;79:290-4

• Insights into the 2025 ESC/EACTS guidelines on the management of patients with valvular heart disease

  SEC Working Group for the 2025 ESC/EACTS guidelines on the management of patients with valvular heart disease and SEC Guidelines Committee

  Rev Esp Cardiol. 2026;79:295-9

• Insights into the 2025 ESC focused update on the management of dyslipidemias

  SEC Working Group for the 2025 ESC focused update on the management of dyslipidemias and SEC Guidelines Committee

  Rev Esp Cardiol. 2026;79:199-203

• Insights into the 2025 ESC guidelines for the management of myocarditis and pericarditis

  SEC Working Group for the 2025 ESC guidelines for the management of myocarditis and pericarditis and SEC Guidelines Committee

  Rev Esp Cardiol. 2026;79:194-8

• Insights into the 2025 ESC guidelines for the management of cardiovascular disease and pregnancy

  SEC Working Group for the 2025 ESC guidelines for the management of cardiovascular disease and pregnancy and SEC Guidelines Committee

  Rev Esp Cardiol. 2026;79:300-4

• Comments on the 2024 ESC guidelines for the management of atrial fibrillation

  SEC Working Group for the 2024 ESC guidelines for the management of atrial fibrillation and SEC Guidelines Committee

  Rev Esp Cardiol. 2025;78:291-5

• Comments on the 2024 ESC guidelines for the management of elevated blood pressure and hypertension

  SEC Working Group for the 2024 ESC guidelines for the management elevated blood pressure and hypertension and SEC Guidelines Committee

  Rev Esp Cardiol. 2025;78:296-300

• Comments on the 2024 ESC guidelines for the management of peripheral arterial and aortic diseases

  SEC Working Group for the 2024 ESC guidelines for the management of peripheral arterial and aortic diseases and SEC Guidelines Committee

  Rev Esp Cardiol. 2025;78:164-9

• Comments on the ESC 2024 guidelines for the management of chronic coronary syndromes

  SEC Working Group for the 2024 ESC guidelines for the management of chronic coronary syndromes and SEC Guidelines Committee

  Rev Esp Cardiol. 2025;78:170-5

• Certification of cardio-oncology-hematology programs: an opportunity to improve the quality of care for patients with cancer

  Pedro Moliner, Teresa López-Fernández, on behalf of the Spanish Society of Cardiology (SEC) Scientific Committee for the accreditation of cardio-oncology-hematology units

  Rev Esp Cardiol. 2024;77:881-4

• Ethics in clinical research: what you should know before starting a study

  Armando Pérez de Prado, Almudena Castro Conde, Ignacio Ferreira-González

  Rev Esp Cardiol. 2024;77:805-8

• Improving the quality of healthcare. Results of the SEC-Excelente accreditation program in heart failure of the Spanish Society of Cardiology

  Manuel Anguita Sánchez, Alejandro Recio Mayoral, Luis Rodríguez Padial

  Rev Esp Cardiol. 2024;77:602-6

• Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts

  Enrique Sánchez-Muñoz, Juan Antonio Requena-Ibáñez, Juan José Badimón

  Rev Esp Cardiol. 2024;77:510-4

• Comments on the 2023 ESC guidelines for the management of cardiomyopathies

  SEC Working Group for the 2023 ESC guidelines for the management of cardiomyopathies and SEC Guidelines Committee

  Rev Esp Cardiol. 2024;77:285-9

• Comments on the 2023 update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

  SEC Working Group for the 2023 update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee

  Rev Esp Cardiol. 2024;77:281-4

• Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes

  SEC Working Group for the 2023 ESC Guidelines on cardiovascular disease in patients with diabetes and SEC Guidelines Committee

  Rev Esp Cardiol. 2024;77:196-200

• Comments on the 2023 ESC guidelines for the management of endocarditis

  SEC Working Group for the 2023 ESC guidelines for the management of endocarditis and SEC Guidelines Committee

  Rev Esp Cardiol. 2024;77:191-5

• Comments on the 2023 ESC guidelines for the management of acute coronary syndromes

  SEC Working Group for the 2023 ESC guidelines for the management of acute coronary syndromes and SEC Guidelines Committee

  Rev Esp Cardiol. 2024;77:201-5

• Cardiology and cardiac surgery: twins separated at birth?

  M. Dolores García-Cosío Carmena, José López-Menéndez

  Rev Esp Cardiol. 2024;77:111-2

• Considerations involved in elective generator replacement of implantable cardioverter-defibrillators: balancing risks, benefits, and individual factors

  Manuel Martínez-Sellés, Marta Pombo, Alejandro Recio-Mayoral, Ana Ayesta, Tomás Datino

  Rev Esp Cardiol. 2024;77:2-5